CEACAM5 and neoplasm: ROC curves showed that circMBOAT2 was a better diagnostic biomarker than CEA/CA19–9/CA72-4, implying that circMBOAT2 was stably expressed in the blood and had the potential to be a diagnostic tumor marker of CRC.